Cargando…

The costs and benefits of a modified biomedical science workforce

Analyses of the biomedical research workforce, the biomedical research enterprise, and its sustainability have identified a number of threats and offered many solutions to alleviate the problems. While a number of these solutions have been implemented, one solution that has not been broadly adopted,...

Descripción completa

Detalles Bibliográficos
Autor principal: Schaller, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876701/
https://www.ncbi.nlm.nih.gov/pubmed/33615153
http://dx.doi.org/10.1096/fba.2020-00091
_version_ 1783650019825418240
author Schaller, Michael D.
author_facet Schaller, Michael D.
author_sort Schaller, Michael D.
collection PubMed
description Analyses of the biomedical research workforce, the biomedical research enterprise, and its sustainability have identified a number of threats and offered many solutions to alleviate the problems. While a number of these solutions have been implemented, one solution that has not been broadly adopted, despite being widely recommended, is to increase the number of staff scientists and reduce dependency on trainees. The perceived impediment of this is the cost. This paper explores the costs associated with laboratory personnel and the benefits, in terms of productivity, associated with different positions in the workforce. The results of this cost‐benefit analysis depend upon the values assigned to different metrics of productivity by individuals and institutions. If first and senior author publications are the most important metrics of productivity, a trainee‐dependent workforce is much more cost effective. If total publications are the most valued metric of productivity, the cost effectiveness of trainee and staff scientists is reasonably equitable. This analysis provides data for consideration when making personnel decisions and for the continued discussion of modification of the biomedical research workforce. It also provides insight into the incentives for modification of the workforce at the grass roots, which must be considered by institutions genuinely committed to workforce modification to sustain the biomedical research enterprise.
format Online
Article
Text
id pubmed-7876701
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78767012021-02-18 The costs and benefits of a modified biomedical science workforce Schaller, Michael D. FASEB Bioadv Research Articles Analyses of the biomedical research workforce, the biomedical research enterprise, and its sustainability have identified a number of threats and offered many solutions to alleviate the problems. While a number of these solutions have been implemented, one solution that has not been broadly adopted, despite being widely recommended, is to increase the number of staff scientists and reduce dependency on trainees. The perceived impediment of this is the cost. This paper explores the costs associated with laboratory personnel and the benefits, in terms of productivity, associated with different positions in the workforce. The results of this cost‐benefit analysis depend upon the values assigned to different metrics of productivity by individuals and institutions. If first and senior author publications are the most important metrics of productivity, a trainee‐dependent workforce is much more cost effective. If total publications are the most valued metric of productivity, the cost effectiveness of trainee and staff scientists is reasonably equitable. This analysis provides data for consideration when making personnel decisions and for the continued discussion of modification of the biomedical research workforce. It also provides insight into the incentives for modification of the workforce at the grass roots, which must be considered by institutions genuinely committed to workforce modification to sustain the biomedical research enterprise. John Wiley and Sons Inc. 2020-12-19 /pmc/articles/PMC7876701/ /pubmed/33615153 http://dx.doi.org/10.1096/fba.2020-00091 Text en © 2020 The Authors. FASEB BioAdvances published by the Federation of American Societies for Experimental Biology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Schaller, Michael D.
The costs and benefits of a modified biomedical science workforce
title The costs and benefits of a modified biomedical science workforce
title_full The costs and benefits of a modified biomedical science workforce
title_fullStr The costs and benefits of a modified biomedical science workforce
title_full_unstemmed The costs and benefits of a modified biomedical science workforce
title_short The costs and benefits of a modified biomedical science workforce
title_sort costs and benefits of a modified biomedical science workforce
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876701/
https://www.ncbi.nlm.nih.gov/pubmed/33615153
http://dx.doi.org/10.1096/fba.2020-00091
work_keys_str_mv AT schallermichaeld thecostsandbenefitsofamodifiedbiomedicalscienceworkforce
AT schallermichaeld costsandbenefitsofamodifiedbiomedicalscienceworkforce